| For: | Li M, Pu XY, Dong LH, Chang PY. Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681 [PMID: 33728312 DOI: 10.12998/wjcc.v9.i7.1676] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i7/1676.htm |
| Number | Citing Articles |
| 1 |
Xiaofang Gao. Systemic chemotherapy for unresectable or recurrent primary thymic adenocarcinoma of enteric type. International Cancer Conference Journal 2022; 12(1) doi: 10.1007/s13691-022-00575-6
|
| 2 |
Alisa K. Sivapiromrat, Meredith J. McAdams, Renee N. Donahue, Carolina Celades, Wiem Lassoued, Hana Bagheri, Elsa Bahiru, Shannon Swift, Christine Feierabend, Susan Sansone, Laercio DaSilva, Eva Szabo, Chen Zhao, Jeffrey Schlom, James L. Gulley, Arun Rajan. Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer. JTO Clinical and Research Reports 2026; 7(8) doi: 10.1016/j.jtocrr.2026.101019
|
| 3 |
Carl He, Georgia Bentick, Patrick Hosking, Andrew Mant. Unresectable Primary Enteric‐Type Thymic Adenocarcinoma Treated With FOLFOX Chemotherapy: A Case Report. Cancer Reports 2025; 8(9) doi: 10.1002/cnr2.70318
|
| 4 |
Renata Quevedo, Sebastian Garcia, John C Cravero, Andrew Horton, Blaine Berger, Roberto I Aguirre. Thymic Adenocarcinoma With Metastasis to the Left Orbit: A Case Report. Cureus 2024; doi: 10.7759/cureus.56139
|